Lauren S Holliday, MD - Medicare Cardiovascular Disease (cardiology) in Columbia, SC

Lauren S Holliday, MD is a medicare enrolled "Internal Medicine - Cardiovascular Disease" physician in Columbia, South Carolina. She went to University Of South Carolina School Of Medicine and graduated in 2009 and has 15 years of diverse experience with area of expertise as Cardiovascular Disease (cardiology). She is a member of the group practice Prisma Health Medical Group-midlands and her current practice location is 8 Richland Medical Park Dr, Suite 300, Columbia, South Carolina. You can reach out to her office (for appointments etc.) via phone at (803) 256-6511.

Lauren S Holliday is licensed to practice in South Carolina (license number 31841) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1033348537.

Contact Information

Lauren S Holliday, MD
8 Richland Medical Park Dr, Suite 300,
Columbia, SC 29203-8005
(803) 256-6511
(803) 744-4731



Physician's Profile

Full NameLauren S Holliday
GenderFemale
SpecialityCardiovascular Disease (cardiology)
Experience15 Years
Location8 Richland Medical Park Dr, Columbia, South Carolina
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Lauren S Holliday attended and graduated from University Of South Carolina School Of Medicine in 2009
  NPI Data:
  • NPI Number: 1033348537
  • Provider Enumeration Date: 07/07/2009
  • Last Update Date: 04/28/2021
  Medicare PECOS Information:
  • PECOS PAC ID: 4385800804
  • Enrollment ID: I20120726000646

Medical Identifiers

Medical identifiers for Lauren S Holliday such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1033348537NPI-NPPES
318418MedicaidSC

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207R00000XInternal Medicine 067761 (Georgia)Secondary
207R00000XInternal Medicine 31841 (South Carolina)Secondary
207RC0000XInternal Medicine - Cardiovascular Disease 31841 (South Carolina)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Prisma Health Richland HospitalColumbia, SCHospital
Newberry County Memorial HospitalNewberry, SCHospital
Prisma Health BaptistColumbia, SCHospital
Prisma Health Baptist ParkridgeColumbia, SCHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Prisma Health Medical Group-midlands5991099707865

News Archive

World's smallest handheld Braille device for the blind

Pulse Data International today introduced the world's smallest handheld Braille device for the blind. The BrailleNote PK weighs less than a pound and has dimensions of 6.8 inches by 3.6 inches by 1.3 inches.

Ohio State study evaluates trans-catheter interatrial shunt device for diastolic heart failure

For the first time in the U.S., a clinical trial is underway that's evaluating a device designed to treat diastolic heart failure. The first patient enrolled in the randomized, blinded study is being treated at The Ohio State University Wexner Medical Center.

Vion Pharmaceuticals files SPA for Onrigin-LDAC combination Phase II/III trial

VION PHARMACEUTICALS, INC. announced today that it had filed a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA) related to a randomized Phase II/III trial of its oncology therapeutic Onrigin™ (laromustine) Injection in combination with low-dose Ara-C (LDAC) in elderly patients with newly diagnosed acute myeloid leukemia (AML). The primary objective for the Phase III part of this study is to determine if Onrigin™ plus LDAC improves overall survival compared with LDAC alone.

New map of natural hazard mortality in the United States

The map, featured in BioMed Central's open access International Journal of Health Geographics, gives a county-level representation of the likelihood of dying as the result of natural events such as floods, earthquakes or extreme weather.

Innovative strategies to reduce infections in health-care settings

Can probiotics prevent pneumonia in patients breathing with the help of ventilators? That's just one question researchers at Washington University School of Medicine in St. Louis hope to answer as part of innovative new studies to reduce infections in health-care settings.

Read more Medical News

› Verified 3 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Lauren S Holliday allows following entities to bill medicare on her behalf.
Entity NameColumbia Heart Clinic Pa
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1245266139
PECOS PAC ID: 3274439575
Enrollment ID: O20031209000158

News Archive

World's smallest handheld Braille device for the blind

Pulse Data International today introduced the world's smallest handheld Braille device for the blind. The BrailleNote PK weighs less than a pound and has dimensions of 6.8 inches by 3.6 inches by 1.3 inches.

Ohio State study evaluates trans-catheter interatrial shunt device for diastolic heart failure

For the first time in the U.S., a clinical trial is underway that's evaluating a device designed to treat diastolic heart failure. The first patient enrolled in the randomized, blinded study is being treated at The Ohio State University Wexner Medical Center.

Vion Pharmaceuticals files SPA for Onrigin-LDAC combination Phase II/III trial

VION PHARMACEUTICALS, INC. announced today that it had filed a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA) related to a randomized Phase II/III trial of its oncology therapeutic Onrigin™ (laromustine) Injection in combination with low-dose Ara-C (LDAC) in elderly patients with newly diagnosed acute myeloid leukemia (AML). The primary objective for the Phase III part of this study is to determine if Onrigin™ plus LDAC improves overall survival compared with LDAC alone.

New map of natural hazard mortality in the United States

The map, featured in BioMed Central's open access International Journal of Health Geographics, gives a county-level representation of the likelihood of dying as the result of natural events such as floods, earthquakes or extreme weather.

Innovative strategies to reduce infections in health-care settings

Can probiotics prevent pneumonia in patients breathing with the help of ventilators? That's just one question researchers at Washington University School of Medicine in St. Louis hope to answer as part of innovative new studies to reduce infections in health-care settings.

Read more Medical News

› Verified 3 days ago

Entity NamePrisma Health Tuomey
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1548625593
PECOS PAC ID: 2163728528
Enrollment ID: O20160310001016

News Archive

World's smallest handheld Braille device for the blind

Pulse Data International today introduced the world's smallest handheld Braille device for the blind. The BrailleNote PK weighs less than a pound and has dimensions of 6.8 inches by 3.6 inches by 1.3 inches.

Ohio State study evaluates trans-catheter interatrial shunt device for diastolic heart failure

For the first time in the U.S., a clinical trial is underway that's evaluating a device designed to treat diastolic heart failure. The first patient enrolled in the randomized, blinded study is being treated at The Ohio State University Wexner Medical Center.

Vion Pharmaceuticals files SPA for Onrigin-LDAC combination Phase II/III trial

VION PHARMACEUTICALS, INC. announced today that it had filed a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA) related to a randomized Phase II/III trial of its oncology therapeutic Onrigin™ (laromustine) Injection in combination with low-dose Ara-C (LDAC) in elderly patients with newly diagnosed acute myeloid leukemia (AML). The primary objective for the Phase III part of this study is to determine if Onrigin™ plus LDAC improves overall survival compared with LDAC alone.

New map of natural hazard mortality in the United States

The map, featured in BioMed Central's open access International Journal of Health Geographics, gives a county-level representation of the likelihood of dying as the result of natural events such as floods, earthquakes or extreme weather.

Innovative strategies to reduce infections in health-care settings

Can probiotics prevent pneumonia in patients breathing with the help of ventilators? That's just one question researchers at Washington University School of Medicine in St. Louis hope to answer as part of innovative new studies to reduce infections in health-care settings.

Read more Medical News

› Verified 3 days ago

Entity NamePrisma Health Medical Group-midlands
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1275988321
PECOS PAC ID: 5991099707
Enrollment ID: O20160802001226

News Archive

World's smallest handheld Braille device for the blind

Pulse Data International today introduced the world's smallest handheld Braille device for the blind. The BrailleNote PK weighs less than a pound and has dimensions of 6.8 inches by 3.6 inches by 1.3 inches.

Ohio State study evaluates trans-catheter interatrial shunt device for diastolic heart failure

For the first time in the U.S., a clinical trial is underway that's evaluating a device designed to treat diastolic heart failure. The first patient enrolled in the randomized, blinded study is being treated at The Ohio State University Wexner Medical Center.

Vion Pharmaceuticals files SPA for Onrigin-LDAC combination Phase II/III trial

VION PHARMACEUTICALS, INC. announced today that it had filed a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA) related to a randomized Phase II/III trial of its oncology therapeutic Onrigin™ (laromustine) Injection in combination with low-dose Ara-C (LDAC) in elderly patients with newly diagnosed acute myeloid leukemia (AML). The primary objective for the Phase III part of this study is to determine if Onrigin™ plus LDAC improves overall survival compared with LDAC alone.

New map of natural hazard mortality in the United States

The map, featured in BioMed Central's open access International Journal of Health Geographics, gives a county-level representation of the likelihood of dying as the result of natural events such as floods, earthquakes or extreme weather.

Innovative strategies to reduce infections in health-care settings

Can probiotics prevent pneumonia in patients breathing with the help of ventilators? That's just one question researchers at Washington University School of Medicine in St. Louis hope to answer as part of innovative new studies to reduce infections in health-care settings.

Read more Medical News

› Verified 3 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Lauren S Holliday is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Lauren S Holliday, MD
Po Box 743904,
Atlanta, GA 30374-3904

Ph: (803) 296-7320
Lauren S Holliday, MD
8 Richland Medical Park Dr, Suite 300,
Columbia, SC 29203-8005

Ph: (803) 256-6511

News Archive

World's smallest handheld Braille device for the blind

Pulse Data International today introduced the world's smallest handheld Braille device for the blind. The BrailleNote PK weighs less than a pound and has dimensions of 6.8 inches by 3.6 inches by 1.3 inches.

Ohio State study evaluates trans-catheter interatrial shunt device for diastolic heart failure

For the first time in the U.S., a clinical trial is underway that's evaluating a device designed to treat diastolic heart failure. The first patient enrolled in the randomized, blinded study is being treated at The Ohio State University Wexner Medical Center.

Vion Pharmaceuticals files SPA for Onrigin-LDAC combination Phase II/III trial

VION PHARMACEUTICALS, INC. announced today that it had filed a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA) related to a randomized Phase II/III trial of its oncology therapeutic Onrigin™ (laromustine) Injection in combination with low-dose Ara-C (LDAC) in elderly patients with newly diagnosed acute myeloid leukemia (AML). The primary objective for the Phase III part of this study is to determine if Onrigin™ plus LDAC improves overall survival compared with LDAC alone.

New map of natural hazard mortality in the United States

The map, featured in BioMed Central's open access International Journal of Health Geographics, gives a county-level representation of the likelihood of dying as the result of natural events such as floods, earthquakes or extreme weather.

Innovative strategies to reduce infections in health-care settings

Can probiotics prevent pneumonia in patients breathing with the help of ventilators? That's just one question researchers at Washington University School of Medicine in St. Louis hope to answer as part of innovative new studies to reduce infections in health-care settings.

Read more News

› Verified 3 days ago


Internal Medicine Doctors in Columbia, SC

William Cole Andrew, D.O.
Cardiovascular Disease
Medicare: Accepting Medicare Assignments
Practice Location: 14 Richland Medical Park Dr Ste 320, Columbia, SC 29203
Phone: 803-434-8721    
Seetharamprasad Madala, M.D.
Cardiovascular Disease
Medicare: Accepting Medicare Assignments
Practice Location: 1801 Sunset Dr, Columbia, SC 29203
Phone: 803-434-4153    Fax: 803-434-4160
Michael Martin,
Cardiovascular Disease
Medicare: Medicare Enrolled
Practice Location: 2 Medical Park Rd, Columbia, SC 29203
Phone: 803-434-6956    
Dr. Terry A Grainger, MD
Cardiovascular Disease
Medicare: Accepting Medicare Assignments
Practice Location: 8 Richland Medical Park Dr Ste 100, Columbia, SC 29203
Phone: 803-434-3800    Fax: 803-744-2759
Dr. Adelero Olayinka Adebajo, M.D.
Cardiovascular Disease
Medicare: Accepting Medicare Assignments
Practice Location: 1520 Laurel St, Columbia, SC 29201
Phone: 803-799-8407    Fax: 803-252-9070
Jeff Z Brooker Jr., MD, RETIRED
Cardiovascular Disease
Medicare: Medicare Enrolled
Practice Location: 1625 Bernardin Ave, Columbia, SC 29204
Phone: 803-251-8985    
Dr. Ronald L Collins, MD
Cardiovascular Disease
Medicare: Accepting Medicare Assignments
Practice Location: 1711 Saint Julian Pl, Columbia, SC 29204
Phone: 803-779-0911    Fax: 803-256-2480

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.